In our opening comments we addressed that a little bit. The value in schedule 1 is that it addresses the intent of the legislation and the intent of the WTO decision, which was to address the very serious diseases, such as HIV/AIDS and malaria and tuberculosis. Having no list would mean that there's a potential for those diseases to be ignored while you try to copy drugs in other categories where they could be either more profitable or more broadly used. So it was really an attempt to define what were considered emergency-type medications.
On April 23rd, 2007. See this statement in context.